Pembrolizumab with or without chemotherapy among older adults with advanced lung adenocarcinoma: a national, nonrandomized open-label phase II trial (Alliance A171901).
      Google Scholar   
Citation:
J Natl Cancer Inst
Year:
2026
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Older Adult
Sec. Committees:
Respiratory    
Pharmas:
 
Grants:
UG1CA189823, K76 AG064431  
Corr. Author:
 
Authors:
                           
Networks:
KAISER, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-OH007, WINCORP   
Study
Alliance-A171901
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: